dacarbazine and lithium

dacarbazine has been researched along with lithium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, W; Han, S; Jiang, Y; Meng, L; Tie, X; Wu, A; Xia, J	1

Other Studies

1 other study(ies) available for dacarbazine and lithium

Article	Year
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling. British journal of cancer, 2017, May-09, Volume: 116, Issue:10 Topics: Aged; Animals; Antibodies, Neutralizing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Fas Ligand Protein; Female; Gene Knockdown Techniques; Glioblastoma; Glycogen Synthase Kinase 3; Humans; Lithium; Male; Mice; Middle Aged; Neoplasm Transplantation; NFATC Transcription Factors; Primary Cell Culture; Protein Transport; Signal Transduction; Survival Rate; Temozolomide; Tumor Suppressor Protein p53	2017

Article

Year

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.

British journal of cancer, 2017, May-09, Volume: 116, Issue:10

Topics: Aged; Animals; Antibodies, Neutralizing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Fas Ligand Protein; Female; Gene Knockdown Techniques; Glioblastoma; Glycogen Synthase Kinase 3; Humans; Lithium; Male; Mice; Middle Aged; Neoplasm Transplantation; NFATC Transcription Factors; Primary Cell Culture; Protein Transport; Signal Transduction; Survival Rate; Temozolomide; Tumor Suppressor Protein p53

2017